Key result
Among 45 fetuses with Ebstein's anomaly, postnatal mortality was 44.4% with monitoring alone, whereas a combination of digoxin, steroids, and maternal hyperoxygenation yielded 0% mortality in 3 cases.
Why the study?
To examine the role of echocardiography in perinatal care, analyze the impact of prenatal treatment on neonatal outcomes, and assess potential environmental risk factors in fetal Ebstein's anomaly in Poland.
Does prenatal treatment with digoxin, steroids, and/or hyperoxygenation improve postnatal mortality in fetuses with Ebstein's anomaly compared to monitoring alone?
Comparison
Fetal monitoring alone vs various prenatal medical treatments
Design
Single-unit observational retrospective study
Authors
Loading...
Combined therapy may reduce mortality in fetal Ebstein's anomaly; hypothesis-generating and requires prospective validation before practice change.
Observational (n=45)
No
Does prenatal treatment with digoxin, steroids, and/or hyperoxygenation improve postnatal mortality in fetuses with Ebstein's anomaly compared to monitoring alone?
In a single-center cohort of fetal Ebstein's anomaly, prenatal treatment strategies showed varying postnatal mortality rates, with a combination of digoxin, steroids, and hyperoxygenation yielding 0% mortality in a very small subgroup (n=3).
Rydzewska et al. (2020) conducted an observational in Fetal Ebstein's anomaly (n=45). Prenatal medical treatment (digoxin, steroids, hyperoxygenation) vs. Fetal monitoring only was evaluated on Postnatal mortality. Among 45 fetuses with Ebstein's anomaly, postnatal mortality was 44.4% with monitoring alone, whereas a combination of digoxin, steroids, and maternal hyperoxygenation yielded 0% mortality in 3 cases.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: